Use of venoactive drugs after surgery for varicose veins: A preliminary study

Daniela Mazzaccaro, Lorenzo Muzzarelli, Alfredo Modafferi, Paolo C. Righini, Alberto M. Settembrini, Giovanni Nano

Research output: Contribution to journalArticle

Abstract

BACKGROUND: The aim of this paper was to assess the use of venoactive drugs (VADs) after surgery for chronic venous disease in our operative unit in terms of patients' compliance to the therapy and a possible effect on the postoperative pain and quality of life (QoL). METHODS: Data of consecutive patients who underwent surgery were retrospectively analyzed. All patients, through telephone interview 90 days after the operation, were asked about taking the VAD (either sulodexide or MPFF) which was recommended during the postoperative period. Data were collected about the duration of therapy, the intensity of perceived pain (0-10 scale) at 1st, 7th and 30th postoperative days (POD), the length of rest from their daily activities and QoL during the first postoperative month (through Italian SF-12 questionnaire). P values < 0.05 were considered significant. Results of patients who took the VAD were compared to those of patients who did not take the VAD (case-controlled study). RESULTS: A total of 132 patients were operated on (43 with endovenous radiofrequency ablation, RFA; 43 with stripping or crossectomy; 46 with phlebectomies). The proportion of patients who took VADs was two thirds, similar among the three groups. Of those, 24% took VADs for less than 30 days. No significant differences were recorded between those who took and those who didn't take any drugs in terms of intensity of pain at 1st, 7th and 30th POD, days of rest from daily activities and QoL. CONCLUSIONS: Irrespectively of the groups, about one third of the patients did not take the recommended VAD postoperatively. No significant difference was recorded between those who took the therapy and those who did not in terms of intensity of postoperative pain, length of rest from daily activities and QoL.

Original languageEnglish
Pages (from-to)79-84
Number of pages6
JournalInternational Angiology
Volume37
Issue number1
DOIs
Publication statusPublished - Feb 1 2018

Fingerprint

Varicose Veins
Pharmaceutical Preparations
Quality of Life
Postoperative Pain
Pain
Patient Compliance
Postoperative Period
Chronic Disease
Therapeutics
Interviews

Keywords

  • Quality of life
  • Therapeutics
  • Varicose veins

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Use of venoactive drugs after surgery for varicose veins : A preliminary study. / Mazzaccaro, Daniela; Muzzarelli, Lorenzo; Modafferi, Alfredo; Righini, Paolo C.; Settembrini, Alberto M.; Nano, Giovanni.

In: International Angiology, Vol. 37, No. 1, 01.02.2018, p. 79-84.

Research output: Contribution to journalArticle

Mazzaccaro, Daniela ; Muzzarelli, Lorenzo ; Modafferi, Alfredo ; Righini, Paolo C. ; Settembrini, Alberto M. ; Nano, Giovanni. / Use of venoactive drugs after surgery for varicose veins : A preliminary study. In: International Angiology. 2018 ; Vol. 37, No. 1. pp. 79-84.
@article{7e3f4c7bce994e6dae64ab3fd19f8490,
title = "Use of venoactive drugs after surgery for varicose veins: A preliminary study",
abstract = "BACKGROUND: The aim of this paper was to assess the use of venoactive drugs (VADs) after surgery for chronic venous disease in our operative unit in terms of patients' compliance to the therapy and a possible effect on the postoperative pain and quality of life (QoL). METHODS: Data of consecutive patients who underwent surgery were retrospectively analyzed. All patients, through telephone interview 90 days after the operation, were asked about taking the VAD (either sulodexide or MPFF) which was recommended during the postoperative period. Data were collected about the duration of therapy, the intensity of perceived pain (0-10 scale) at 1st, 7th and 30th postoperative days (POD), the length of rest from their daily activities and QoL during the first postoperative month (through Italian SF-12 questionnaire). P values < 0.05 were considered significant. Results of patients who took the VAD were compared to those of patients who did not take the VAD (case-controlled study). RESULTS: A total of 132 patients were operated on (43 with endovenous radiofrequency ablation, RFA; 43 with stripping or crossectomy; 46 with phlebectomies). The proportion of patients who took VADs was two thirds, similar among the three groups. Of those, 24{\%} took VADs for less than 30 days. No significant differences were recorded between those who took and those who didn't take any drugs in terms of intensity of pain at 1st, 7th and 30th POD, days of rest from daily activities and QoL. CONCLUSIONS: Irrespectively of the groups, about one third of the patients did not take the recommended VAD postoperatively. No significant difference was recorded between those who took the therapy and those who did not in terms of intensity of postoperative pain, length of rest from daily activities and QoL.",
keywords = "Quality of life, Therapeutics, Varicose veins",
author = "Daniela Mazzaccaro and Lorenzo Muzzarelli and Alfredo Modafferi and Righini, {Paolo C.} and Settembrini, {Alberto M.} and Giovanni Nano",
year = "2018",
month = "2",
day = "1",
doi = "10.23736/S0392-9590.17.03875-5",
language = "English",
volume = "37",
pages = "79--84",
journal = "International Angiology",
issn = "0392-9590",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "1",

}

TY - JOUR

T1 - Use of venoactive drugs after surgery for varicose veins

T2 - A preliminary study

AU - Mazzaccaro, Daniela

AU - Muzzarelli, Lorenzo

AU - Modafferi, Alfredo

AU - Righini, Paolo C.

AU - Settembrini, Alberto M.

AU - Nano, Giovanni

PY - 2018/2/1

Y1 - 2018/2/1

N2 - BACKGROUND: The aim of this paper was to assess the use of venoactive drugs (VADs) after surgery for chronic venous disease in our operative unit in terms of patients' compliance to the therapy and a possible effect on the postoperative pain and quality of life (QoL). METHODS: Data of consecutive patients who underwent surgery were retrospectively analyzed. All patients, through telephone interview 90 days after the operation, were asked about taking the VAD (either sulodexide or MPFF) which was recommended during the postoperative period. Data were collected about the duration of therapy, the intensity of perceived pain (0-10 scale) at 1st, 7th and 30th postoperative days (POD), the length of rest from their daily activities and QoL during the first postoperative month (through Italian SF-12 questionnaire). P values < 0.05 were considered significant. Results of patients who took the VAD were compared to those of patients who did not take the VAD (case-controlled study). RESULTS: A total of 132 patients were operated on (43 with endovenous radiofrequency ablation, RFA; 43 with stripping or crossectomy; 46 with phlebectomies). The proportion of patients who took VADs was two thirds, similar among the three groups. Of those, 24% took VADs for less than 30 days. No significant differences were recorded between those who took and those who didn't take any drugs in terms of intensity of pain at 1st, 7th and 30th POD, days of rest from daily activities and QoL. CONCLUSIONS: Irrespectively of the groups, about one third of the patients did not take the recommended VAD postoperatively. No significant difference was recorded between those who took the therapy and those who did not in terms of intensity of postoperative pain, length of rest from daily activities and QoL.

AB - BACKGROUND: The aim of this paper was to assess the use of venoactive drugs (VADs) after surgery for chronic venous disease in our operative unit in terms of patients' compliance to the therapy and a possible effect on the postoperative pain and quality of life (QoL). METHODS: Data of consecutive patients who underwent surgery were retrospectively analyzed. All patients, through telephone interview 90 days after the operation, were asked about taking the VAD (either sulodexide or MPFF) which was recommended during the postoperative period. Data were collected about the duration of therapy, the intensity of perceived pain (0-10 scale) at 1st, 7th and 30th postoperative days (POD), the length of rest from their daily activities and QoL during the first postoperative month (through Italian SF-12 questionnaire). P values < 0.05 were considered significant. Results of patients who took the VAD were compared to those of patients who did not take the VAD (case-controlled study). RESULTS: A total of 132 patients were operated on (43 with endovenous radiofrequency ablation, RFA; 43 with stripping or crossectomy; 46 with phlebectomies). The proportion of patients who took VADs was two thirds, similar among the three groups. Of those, 24% took VADs for less than 30 days. No significant differences were recorded between those who took and those who didn't take any drugs in terms of intensity of pain at 1st, 7th and 30th POD, days of rest from daily activities and QoL. CONCLUSIONS: Irrespectively of the groups, about one third of the patients did not take the recommended VAD postoperatively. No significant difference was recorded between those who took the therapy and those who did not in terms of intensity of postoperative pain, length of rest from daily activities and QoL.

KW - Quality of life

KW - Therapeutics

KW - Varicose veins

UR - http://www.scopus.com/inward/record.url?scp=85040921676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040921676&partnerID=8YFLogxK

U2 - 10.23736/S0392-9590.17.03875-5

DO - 10.23736/S0392-9590.17.03875-5

M3 - Article

C2 - 28976172

AN - SCOPUS:85040921676

VL - 37

SP - 79

EP - 84

JO - International Angiology

JF - International Angiology

SN - 0392-9590

IS - 1

ER -